Ali Behbahani Insider Trading $TRVI Trevi Therapeutics, Inc.
Get free email notifications about insider trading for Ali Behbahani.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ali Behbahani. Ali Behbahani is 10% Owner in Marker Therapeutics, Inc. ($MRKR) and Director in NEVRO CORP ($NVRO) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and Director in Nkarta, Inc. ($NKTX).
Ali Behbahani in Trevi Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 5,938,562 shares
Latest Transaction: Apr 13 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ali Behbahani in Trevi Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, AKUS, BDTX, CRSP, GNCA, MRKR, MTCR, MIRM, NVRO, NKTX, OYST, RGLS, TRVI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13 2020 | TRVI | Trevi Therapeutics ... | Behbahani Ali | 10% Owner | Option Exercise | X | 0.00 | 1,500,000 | 1,500 | 0 | |
| Apr 13 2020 | TRVI | Trevi Therapeutics ... | Behbahani Ali | 10% Owner | Sell | S | 2.66 | 564 | 1,500 | 5,937,998 | 5.9 M to 5.9 M (-0.01 %) |
| Apr 13 2020 | TRVI | Trevi Therapeutics ... | Behbahani Ali | 10% Owner | Buy | X | 0.00 | 1,500,000 | 1,500 | 5,938,562 | 4.4 M to 5.9 M (+33.79 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Behbahani Ali | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Behbahani Ali | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Behbahani Ali | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
| May 13 2019 | TRVI | Trevi Therapeutics ... | Behbahani Ali | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
Page: 1